{
    "nctId": "NCT02470819",
    "briefTitle": "Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer",
    "officialTitle": "A Two Arm Pilot Study Utilizing Molecular Profiling to Find Potential Targets and Influence Treatments for Patients With Metastatic Breast Cancer or Advanced Gynecological Malignancies",
    "overallStatus": "WITHDRAWN",
    "conditions": "Metastatic Breast Cancer, Breast Tumor, Advanced Gynecologic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Progression-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Life expectancy of \\>3 months\n* Diagnosis of metastatic breast cancer or an advanced gynecological malignancy with measurable disease\n* Age greater than or equal to 18 years\n* ECOG performance status of 0-1\n* Able to undergo two biopsies to obtain tissue with first biopsy required and second biopsy optional\n* Have failed or unable to tolerate previous treatment regimen\n* Adequate organ and bone marrow function as defined by ANC \u2265 1.5 x 109/L; Hgb 9 g/dL; platelets greater than 100 x 109/L; creatinine \u2264 1.5 mg/dL; bilirubin \u2264 2.5 x ULN; AST and ALT \u2264 2.5 x ULN (or \u2264 5 x ULN if due to underlying liver metastases); INR \u2264 1.5 x ULN (except in the case of anticoagulation therapy)\n\nExclusion Criteria:\n\n* Metastatic lesions that are not accessible to biopsy\n* Symptomatic CNS metastasis\n* Previous history of another malignancy within 5 years of study entry\n* Uncontrolled concurrent illness\n* Known HIV, HBB, and/or HCV infection\n* Pregnant or breast feeding or childbearing potential and not using adequate birth control",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}